Breaks Categories: News

WednesdayApr 24, 2024 9:41 am

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDA

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has made a key announcement regarding the development of its proprietary PAX-101, an IV formulation of suramin. According to the announcement, the company has completed execution of three pivotal registration/validation batches of PAX-101. The company noted that the completion is an “important milestone” in enabling a New Drug Application (“NDA”) submission to the U.S. Food and Drug Administration (FDA), which it plans to complete by the last quarter of 2024. The NDA, along with the approval of the FDA, is a strategic step in the company’s efforts…

Continue Reading

WednesdayApr 24, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO to Present at Planet MicroCap Showcase

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, will be spotlighted at the May 1, 2024, Planet MicroCap Showcase in Las Vegas. According to the announcement, Tonix Pharmaceuticals CEO Seth Lederman, MD, is slated to present at the event. During the presentation Lederman will provide an overview of data from the recently reported positive phase 3 RESILIENT trial of Tonmya(TM) (also known as TNX-102 SL) for the management of fibromyalgia. To view the full press release, visit https://nnw.fm/4OJlE About Tonix Pharmaceuticals Holding Corp. Tonix is a biopharmaceutical company focused on developing, licensing…

Continue Reading

TuesdayApr 23, 2024 4:16 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024

  CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced that its Chief Executive Officer John Climaco will present at the LSX World Congress 2024. Climaco is slated to present at 4:15 PM (GMT+1) on Monday, April 29, 2024, at the event taking place in London, England. In addition to the presentation, CNSP announced that its management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. To view…

Continue Reading

TuesdayApr 23, 2024 3:27 pm

NetworkNewsBreaks – Diamond Lake Minerals Inc. (DLMI), BOXABL Partnership Highlighted in Proactive Article

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens, was featured in an article published by Proactive. The piece discusses the recently unveiled collaboration between Diamond Lake Minerals and modular home builder BOXABL Inc. to develop communities known as BOXABL Villages. DLMI expects the partnership to streamline processes and shorten timelines to residents’ possession of their BOXABL homes and believes its leadership in security tokens combined with traditional means will “create unique opportunities for these villages to thrive and scale.” “DLMI and BOXABL are working together to develop…

Continue Reading

TuesdayApr 23, 2024 3:09 pm

NetworkNewsBreaks – Energy and Water Development Corp. (EAWD) Makes Key Move to Strengthen Compliance and Legal Operations

Energy and Water Development Corp. (OTCQB: EAWD), a leading water and energy solutions provider, has announced the appointment of Bevilacqua PLLC as its new counsel for matters related to the U.S. Securities and Exchange Commission (“SEC”) and capital markets, effective April 2024. Bevilacqua PLLC, under the expert leadership of Louis Bevilacqua, will bring a wealth of experience and a proven track record in SEC regulatory and capital markets legal advice to EAWD. The move is part of EAWD’s strategic efforts to enhance its legal capabilities and ensure continued excellence in compliance practices. “We are excited to welcome Mr. Louis Bevilacqua…

Continue Reading

TuesdayApr 23, 2024 3:08 pm

NetworkNewsBreaks – SUIC Worldwide Holdings Ltd (SUIC) Featured in Bell2Bell Podcast

SUIC Worldwide Holdings (OTC: SUIC), a provider of research and development, venture financing and investment for private and public companies, was featured in the latest episode of the Bell2Bell Podcast as part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. SUIC CEO Hank Wang joined the program to provide an overview of the company and its business model. “SUIC Worldwide Holdings targets opportunities to enhance and streamline existing supply chain and financial processes. SUIC is the majority and U.S. operating shareholder of Beneway Holdings Group, which is planning to file an S-1 for an IPO…

Continue Reading

TuesdayApr 23, 2024 2:33 pm

NetworkNewsBreaks – Zoned Properties Inc. (ZDPY) Announces $1M Stock Repurchase Program

Zoned Properties (OTCQB: ZDPY), a leading real estate development firm for emerging and highly regulated industries including legalized cannabis, today announced that its board of directors has approved a share repurchase program, pursuant to which the company is authorized to purchase up to $1 million of its common stock over an unlimited time period. “As our business continues to outperform in a challenging overall operating environment, we are thrilled to announce this share repurchase program. The approval of this program demonstrates the management team’s and board’s confidence in our prospects for the future, ongoing operational strength and sound capital structure,”…

Continue Reading

TuesdayApr 23, 2024 1:15 pm

NetworkNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Strong Revenue Growth for Q1 2024

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company today announced its preliminary financial results for Q1 2024, which concluded on March 31, 2024. Among the highlights, the company reported healthy revenue growth of 30% in Q1 2024 over the prior year with approximately $4.3 million in quarterly revenue. “The company’s addition of its Fr8Fleet offering in 2022 was the right strategic response to the market dynamics of the Mexican…

Continue Reading

TuesdayApr 23, 2024 11:47 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Enters Exclusive Supplier Agreement with Major Sports Brand Licensee

Nutriband (NASDAQ: NTRB, NTRBW) today announced that following its engagement by Fit For Life Group (“FFL”), a major brand license holder, on April 19, 2024, the companies fully executed an exclusive supplier agreement for FFL’s new product launch under one of its top brands. According to the announcement, Nutriband’s wholly owned contract manufacturing subsidiary, Active Intelligence, will act as manufacturer. Founded in 2016, FFL has become a market leader for fitness equipment and yoga accessories. FFL has amassed an impressive portfolio of brands with a commitment to creating innovative products for everyone, from beginners to pros. FFL’s distribution and retail…

Continue Reading

MondayApr 22, 2024 3:45 pm

NetworkNewsBreaks – NRx Pharmaceuticals Inc. Releases Pricing of Public Offering, Expected to Result in Estimated $2M

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has announced the pricing of its underwritten public offering. The offering is comprised of shares of NRXP common stock at $3.30 per share, resulting in gross proceeds of an estimated $2 million before standard underwriting deductions and other expenses. According to the announcement, NRx Pharmaceuticals also granted a 45-day option to underwriters. The option allows the purchase of up to 91,050 additional shares of common stock to cover overallotments; the shares will be available at the public offering price less the underwriting discounts. NRx Pharmaceuticals anticipates using funds from the offering for working capital,…

Continue Reading